Blog
RSS FeedPosted by Michael Wonder on 20 Nov 2020
Trump Administration announces prescription drug payment model to put American patients first
20 November 2020 - In support of President Trump’s historic commitment to lowering drug prices for American patients, HHS Secretary Alex ...
Posted by Michael Wonder on 20 Nov 2020
Update on remdesivir - EMA will evaluate new data from Solidarity trial
20 November 2020 - EMA is aware that the World Health Organization has updated its guidelines advising against the use ...
Posted by Michael Wonder on 20 Nov 2020
Lilly's neutralising antibody bamlanivimab (LY-CoV555) receives interim authorisation from Health Canada as a treatment for COVID-19
20 November 2020 - Bamlanivimab emerged from collaboration between Lilly and Vancouver-based AbCellera. ...
Posted by Michael Wonder on 20 Nov 2020
Imfinzi approved in the US for less-frequent, fixed-dose use
20 November 2020 - Four-week dosing now approved in all Imfinzi indications, reducing medical visits and improving patient convenience ...
Posted by Michael Wonder on 20 Nov 2020
PTC Therapeutics announces key regulatory designations for PTC596 to advance treatment of two rare oncology indications
18 November 2020 - PTC Therapeutics today announced that the United States FDA has granted PTC596 both orphan drug designation and ...
Posted by Michael Wonder on 20 Nov 2020
FDA authorises drug combination for treatment of COVID-19
19 November 2020 - Today, the U.S. FDA issued an emergency use authorisation for the drug baricitinib, in combination with ...
Posted by Michael Wonder on 19 Nov 2020
NICE recommends another medicine for patients with multiple myeloma
18 November 2020 - Recommended for listing in the Cancer Drugs Fund. ...
Posted by Michael Wonder on 19 Nov 2020
Lantheus announces FDA approval of Definity room temperature
18 November 2020 - Lantheus today announced the U.S. FDA has approved the supplemental new drug application for Definity Room ...
Posted by Michael Wonder on 19 Nov 2020
Brickell Biotech announces launch date for sofpironium bromide 5% gel (Ecclock) in Japan by its development partner, Kaken Pharmaceutical
18 November 2020 - Kaken plans to launch Ecclock for the treatment of primary axillary hyperhidrosis in Japan on 26 November ...
Posted by Michael Wonder on 19 Nov 2020
Why the new Amazon Pharmacy could pose a real threat to drugstores
17 November 2020 - In its latest disruptive move, Amazon on Tuesday unveiled Amazon Pharmacy that would make it possible ...
Posted by Michael Wonder on 19 Nov 2020
Consideration of value-based pricing for treatments and vaccines is important, even in the COVID-19 pandemic
19 November 2020 - Prices send signals about consumer preferences and thus stimulate producers to make more of what people want. ...
Posted by Michael Wonder on 19 Nov 2020
Alvotech announces that the U.S. FDA and EMA have accepted regulatory submissions for AVT02, a proposed biosimilar to Humira (adalimumab)
19 November 2020 - Alvotech is developing AVT02 as a proposed biosimilar to Humira (adalimumab) with high concentration (100 mg/mL) dosage ...
Posted by Michael Wonder on 19 Nov 2020
Trifarotene in moderate acne: no study data for the assessment of the added benefit
16 November 2020 - Only studies with placebo comparisons despite many affected people and existing treatment alternatives. ...
Posted by Michael Wonder on 19 Nov 2020
NICE is getting ready for the end of the transition period after Brexit
19 November 2020 - NICE has a key role in evaluation and access to new and innovative products for the health ...
Posted by Michael Wonder on 19 Nov 2020
Kyowa Kirin announces approval for partial change of rituximab biosimilar received by Sandoz in Japan
18 November 2020 - Kyowa Kirin today announced that Sandoz KK, its strategic partner of the anti-CD20 monoclonal antibody rituximab ...